Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Authors :: Allen, Larry A.
Felker, G. Michael
Pocock, Stuart
McMurray, John J. V.
Pfeffer, Marc A.
Swedberg, Karl
Duolao Wang
Yusuf, Salim
Michelson, Eric L.
Granger, Christopher B.
Source :: European Journal of Heart Failure. Feb2009, Vol. 11 Issue 2, p170-177. 8p. 3 Charts, 2 Graphs.
Publication Year :: 2009
Abstract: Aims: The prevalence and importance of liver function test (LFT) abnormalities in a large contemporary cohort of heart failure patients have not been systematically evaluated. [ABSTRACT FROM PUBLISHER]

Subjects :: *HEART failure
*LIVER function tests
*MORTALITY
*HEART diseases
*ALANINE aminotransferase

Full Text Access

Tools